Posted in | News

U.S. Concrete Acquires Ready-Mixed Concrete Assets and Property of Diamond Concrete

U.S. Concrete, Inc. announced today that it has acquired the ready-mixed concrete assets and property of Diamond Concrete, Inc. on Staten Island, N.Y. This acquisition expands U.S. Concrete's footprint to the eastern side of Staten Island, allowing U.S. Concrete to more efficiently provide concrete to the increasing number of commercial and residential construction projects on Staten Island planned for the coming years.

The acquisition includes one ready-mixed concrete facility and related real estate, along with 24 ready-mixed concrete trucks.

"We are committed to growing our footprint through bolt-on acquisitions to better deliver high quality concrete with the highest level of customer service. Adding this site displays our commitment to increasing our ability to better serve the greater New York City construction market," said U.S. Concrete President and Chief Executive Officer, William J. Sandbrook.

About U.S. Concrete

U.S. Concrete services the construction industry in several major markets in the United States through its two business segments: ready-mixed concrete and aggregate products. The Company has 120 standard ready-mixed concrete plants, 16 volumetric ready-mixed concrete facilities, and 10 producing aggregates facilities. During 2013, U.S. Concrete produced approximately 5.2 million cubic yards of ready-mixed concrete and approximately 3.6 million tons of aggregates. For more information on U.S. Concrete, visit www.us-concrete.com.

Source: http://www.us-concrete.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.